iHealth Labs on Monday unveiled two new additions to its suite of devices — the iHealth Wireless Smart Gluco-Monitoring System and iHealth Pulse Oximeter — at the 2013 Consumer Electronics Show in Las Vegas.
You're invited to submit a post for the Sixth Annual Retail Clinician Education Congress. The Retail Clinician Education Congress will be featuring CE break-out sessions and panel discussions on topics submitted by retail clinicians and organizations.
The U.S. Food and Drug Administration on Monday approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral therapy, a combination of medicines used to treat HIV infection.
The Food and Drug Administration last week approved the anti-clotting drug Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots in patients with atrial fibrillation that is not caused by a heart valve problem. Eliquis is manufactured by Bristol-Myers Squibb, and marketed by BMS and Pfizer.
Mylan announced that its subsidiary, Mylan Pharmaceuticals, has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug applications for rizatriptan benzoate orally disintegrating tablets and rizatriptan benzoate tablets, generic versions of Merck's Maxalt MLT Tablets and Maxalt Tablets.